4.6 Article

Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism

期刊

MODERN PATHOLOGY
卷 19, 期 1, 页码 122-129

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/modpathol.3800497

关键词

congenital hyperinsulinism; ATP-sensitive potassium channel; adenomatous hyperplasia; loss of heterozygosity; p57(kip2); nesidioblastosis

资金

  1. NCRR NIH HHS [M01 RR 00240] Funding Source: Medline
  2. NIDDK NIH HHS [R01 DK 56268] Funding Source: Medline
  3. NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000240] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056268] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Congenital hyperinsulinism is a rare pancreatic endocrine cell disorder that has been categorized histologically into diffuse and focal forms. In focal hyperinsulinism, the pancreas contains a focus of endocrine cell adenomatous hyperplasia, and the patients have been reported to possess paternally inherited mutations of the ABCC8 and KCNJ11 genes, which encode subunits of an ATP-sensitive potassium channel (K-ATP). In addition, the hyperplastic endocrine cells show loss of maternal 11p15, where imprinted genes such as p57(kip2) reside. In order to evaluate whether all cases of focal hyperinsulinism are caused by this mechanism, 56 pancreatectomy specimens with focal hyperinsulinism were tested for the loss of maternal allele by two methods: immunohistochemistry for p57(kip2) (n = 56) and microsatellite marker analysis (n = 27). Additionally, 49 patients were analyzed for K-ATP mutations. Out of 56 focal lesions, 48 demonstrated clear loss of p57(kip2) expression by immunohistochemistry. The other eight lesions similarly showed no nuclear labeling, but the available tissue was not ideal for definitive interpretation. Five of these eight patients had paternal K-ATP mutations, of which four demonstrated loss of maternal 11p15 within the lesion by microsatellite marker analysis. All of the other three without a paternal K-ATP mutation showed loss of maternal 11p15. K-ATP mutation analysis identified 32/49 cases with paternal mutations. There were seven patients with nonmaternal mutations whose paternal DNA material was not available, and one patient with a mutation that was not present in either parent's DNA. These eight patients showed either loss of p57(kip2) expression or loss of maternal 11p15 region by microsatellite marker analysis, as did the remaining nine patients with no identifiable K-ATP coding region mutations. The combined results from the immunohistochemical and molecular methods indicate that maternal 11p15 loss together with paternal K-ATP mutation is the predominant causative mechanism of focal hyperinsulinism.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据